Eli Lilly & Co (LLY) - Immunology Revenue (I:ELCLFETH)
Level Chart
Basic Info
|
Eli Lilly & Co (LLY) - Immunology Revenue is at a current level of 1.362B, up from 1.256B last quarter and up from 1.186B one year ago. This is a change of 8.51% from last quarter and 14.90% from one year ago. |
|
Immunology Revenue refers to the total revenue generated by Eli Lilly & Co from its products and treatments related to immunology within a specific reporting period. |
| Report | Fiscal.ai |
| Category | Segments & KPIs |
| Region | United States |
| Source | Fiscal.ai |
|
Data provided via Fiscal.ai |
Stats
| Last Value | 1.362B |
| Latest Period | Sep 2025 |
| Last Updated | Dec 18 2025, 15:08 EST |
| Next Release | Feb 27 2026, 08:30 EST (E) |
| Average Growth Rate | 27.03% |
| Value from Last Quarter | 1.256B |
| Change from Last Quarter | 8.51% |
| Value from 1 Year Ago | 1.186B |
| Change from 1 Year Ago | 14.90% |
| Frequency | Quarterly |
| Unit | USD |
| Adjustment | N/A |
| Download Source File | Upgrade |
Historical Data
| Date | Value |
|---|---|
| September 30, 2025 | 1.362B |
| June 30, 2025 | 1.256B |
| March 31, 2025 | 1.088B |
| December 31, 2024 | 1.291B |
| September 30, 2024 | 1.186B |
| June 30, 2024 | 1.082B |
| March 31, 2024 | 834.00M |
| December 31, 2023 | 1.104B |
| September 30, 2023 | 986.90M |
| June 30, 2023 | 928.50M |
| March 31, 2023 | 777.80M |
| December 31, 2022 | 933.60M |
| Date | Value |
|---|---|
| September 30, 2022 | 866.40M |
| June 30, 2022 | 796.50M |
| March 31, 2022 | 748.10M |
| December 31, 2021 | 956.60M |
| September 30, 2021 | 1.005B |
| June 30, 2021 | 785.50M |
| March 31, 2021 | 613.90M |
| December 31, 2020 | 700.70M |
| September 30, 2020 | 627.10M |
| June 30, 2020 | 548.30M |
| March 31, 2020 | 585.80M |
| December 31, 2019 | 409.50M |
News
Basic Info
|
Eli Lilly & Co (LLY) - Immunology Revenue is at a current level of 1.362B, up from 1.256B last quarter and up from 1.186B one year ago. This is a change of 8.51% from last quarter and 14.90% from one year ago. |
|
Immunology Revenue refers to the total revenue generated by Eli Lilly & Co from its products and treatments related to immunology within a specific reporting period. |
| Report | Fiscal.ai |
| Category | Segments & KPIs |
| Region | United States |
| Source | Fiscal.ai |
|
Data provided via Fiscal.ai |
Stats
| Last Value | 1.362B |
| Latest Period | Sep 2025 |
| Last Updated | Dec 18 2025, 15:08 EST |
| Next Release | Feb 27 2026, 08:30 EST (E) |
| Average Growth Rate | 27.03% |
| Value from Last Quarter | 1.256B |
| Change from Last Quarter | 8.51% |
| Value from 1 Year Ago | 1.186B |
| Change from 1 Year Ago | 14.90% |
| Frequency | Quarterly |
| Unit | USD |
| Adjustment | N/A |
| Download Source File | Upgrade |